UnitedHealth Group Incorporated (NYSE:UNH) issued its fiscal 2023 EPS guidance of $24.40—24.90 (vs. Street’s $24.92). Revenues are projected to be robust at $357—360 billion (vs. Street’s $352 billion), while cash flows are expected to be strong at $27—28 billion.
The mid-point of the new EPS outlook equates to 12% growth over the mid-point of 2022 guidance of $21.85—22.05.
Analysts at Oppenheimer estimate that the company has beaten its initial mid-point by an average of 4.5% over the last five and ten years. At first glance, the outlook appears solid, especially considering the company’s conservatism and consistency are likely to drive an upside to this outlook.